R. Admon, R. H. Kaiser, D. G. Dillon, M. Beltzer, F. Goer et al., Dopaminergic enhancement of striatal response to reward in major depression, Am. J. Psychiatry, vol.174, issue.4, pp.378-386, 2017.

A. O. Ahmed, B. Kirkpatrick, S. Galderisi, A. Mucci, A. Rossi et al., Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia, Schizophr. Bull, vol.45, issue.2, pp.305-314, 2019.

S. Alghowinem, R. Goecke, M. Wagner, J. Epps, M. Breakspear et al., Detecting depression: A comparison between spontaneous and read speech, 2013 IEEE International Conference on Acoustics, Speech and Signal Processing, pp.7547-7551, 2013.

O. P. Almeida, A. H. Ford, and L. Flicker, Systematic review and meta-analysis of randomized placebo-controlled trials of folate and vitamin B12 for depression, Int. Psychogeriat./IPA, vol.27, issue.5, pp.727-737, 2015.

, Diagnostic and Statistical Manual of Mental Disorders (DSM-5®), American Psychiatric Association, 2013.

D. Arnone, S. Mckie, R. Elliott, G. Juhasz, E. J. Thomas et al., State-dependent changes in hippocampal grey matter in depression, Mol. Psychiatry, vol.18, issue.12, pp.1265-1272, 2013.

A. H. Ashok, T. R. Marques, S. Jauhar, M. M. Nour, G. M. Goodwin et al., The dopamine hypothesis of bipolar affective disorder: The state of the art and implications for treatment, Mol. Psychiatry, vol.22, issue.5, pp.666-679, 2017.

M. Ballmaier, F. Schlagenhauf, A. W. Toga, J. Gallinat, M. Koslowski et al., Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia, Schizophr. Res, vol.106, issue.2-3, pp.140-147, 2008.

D. M. Barch and E. C. Dowd, Goal representations and motivational drive in schizophrenia: The role of prefrontal-striatal interactions, Schizophr. Bull, vol.36, issue.5, pp.919-934, 2010.

D. M. Barch, M. T. Treadway, and N. Schoen, Effort, anhedonia, and function in schizophrenia: Reduced effort allocation predicts amotivation and functional impairment, J. Abnorm. Psychol, vol.123, issue.2, pp.387-397, 2014.

D. M. Barch, D. Pagliaccio, and K. Luking, Mechanisms underlying motivational deficits in psychopathology: Similarities and differences in depression and schizophrenia, Curr. Top. Behav. Neurosci, vol.27, pp.411-449, 2016.

A. Bender, K. E. Hagan, and N. Kingston, The association of folate and depression: A meta-analysis, J. Psychiatr. Res, vol.95, pp.9-18, 2017.

A. Benoit, . Bodnar, . Michael, . Malla, K. Ashok et al., The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: A voxel-based morphometry study. Front, Psychiatry/Front. Res. Found, vol.3, p.42, 2012.

H. Berenbaum and T. F. Oltmanns, Emotional experience and expression in schizophrenia and depression, J. Abnorm. Psychol, vol.101, issue.1, pp.37-44, 1992.

H. Berenbaum, J. G. Kerns, L. L. Vernon, and J. J. Gomez, Cognitive correlates of schizophrenia signs and symptoms: I. Verbal communication disturbances, Psychiatry Res, vol.159, issue.1-2, pp.147-156, 2008.

, Bipolar Disorder and Schizophrenia Working Group of the Psychiatric Genomics Consortium, Cell, vol.173, issue.7, pp.1705-1715, 2018.

T. Boozalis, A. L. Teixeira, R. Cho, . Young-jin, . Okusaga et al., C-reactive protein correlates with negative symptoms in patients with schizophrenia, Front. Public Health, vol.5, p.360, 2017.

C. Bortolon, A. Macgregor, . Capdevielle, . Delphine, and S. Raffard, Apathy in schizophrenia: A review of neuropsychological and neuroanatomical studies, Neuropsychologia, vol.118, pp.22-33, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01743903

J. D. Bremner, M. Vythilingam, E. Vermetten, A. Nazeer, J. Adil et al., Reduced volume of orbitofrontal cortex in major depression, Biol. Psychiatry, vol.51, issue.4, pp.273-279, 2002.

E. J. Bromet, R. Kotov, L. J. Fochtmann, G. A. Carlson, M. Tanenberg-karant et al., Diagnostic shifts during the decade following first admission for psychosis, Am. J. Psychiatry, vol.168, issue.11, pp.1186-1194, 2011.

A. G. Cardno and M. J. Owen, Genetic relationships between schizophrenia, bipolar disorder, and schizoaffective disorder, Schizophr. Bull, vol.40, issue.3, pp.504-515, 2014.

T. T. Chong, .. Husain, and M. , The role of dopamine in the pathophysiology and treatment of apathy. Prog, Brain Res, vol.229, pp.389-426, 2016.

J. Chuang, G. K. Murray, . Metastasio, . Antonio, . Segarra et al., Brain structural signatures of negative symptoms in depression and schizophrenia. Front, Psychiatry/Front. Res. Found, vol.5, p.116, 2014.

Y. S. Chung and D. M. Barch, Frontal-striatum dysfunction during reward processing: Relationships to amotivation in schizophrenia, J. Abnorm. Psychol, vol.125, issue.3, pp.453-469, 2016.

P. S. Churchland and P. Winkielman, Modulating social behavior with oxytocin: How does it work? What does it mean?, Horm. Behav, vol.61, issue.3, pp.392-399, 2012.

M. Cléry-melin, . Jollant, . Fabrice, and P. Gorwood, Reward systems and cognitions in major depressive disorder, CNS Spect. November, pp.1-14, 2018.

A. S. Cohen, J. E. Mcgovern, T. J. Dinzeo, and M. A. Covington, Speech deficits in serious mental illness: A cognitive resource issue?, Schizophr. Res, vol.160, issue.1-3, pp.173-179, 2014.

A. S. Cohen, K. R. Mitchell, and B. Elvevåg, What do we really know about blunted vocal affect and alogia? A meta-analysis of objective assessments, Schizophr. Res, vol.159, issue.2-3, pp.533-538, 2014.

J. W. Cook, M. E. Piper, A. M. Leventhal, T. R. Schlam, M. C. Fiore et al., Anhedonia as a component of the tobacco withdrawal syndrome, J. Abnorm. Psychol, vol.124, issue.1, pp.215-225, 2015.

S. H. Lee, S. Ripke, B. M. Neale, S. V. Faraone, S. M. Purcell et al., Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs, Nat. Genet, vol.45, issue.9, pp.984-994, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00864642

U. Dannlowski, P. Ohrmann, J. Bauer, H. Kugel, V. Arolt et al., Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: A 3 T fMRI study, J. Psychiatry Neurosci. JPN, vol.32, issue.6, pp.423-429, 2007.

K. Dedovic and J. Ngiam, The cortisol awakening response and major depression: examining the evidence, Neuropsychiatr. Dis. Treat, vol.11, pp.1181-1189, 2015.

D. Hert, . Marc, . Wampers, . Martien, . Jendricko et al., Effects of Cannabis Use on Age at Onset in Schizophrenia and Bipolar Disorder, Schizophr. Res, vol.126, issue.1-3, pp.270-276, 2011.

L. R. Demenescu, R. Renken, R. Kortekaas, M. Van-tol, J. B. Marsman et al., Neural correlates of perception of emotional facial expressions in out-patients with mild-tomoderate depression and anxiety. A multicenter fMRI study, Psychol. Med, vol.41, issue.11, pp.2253-2264, 2011.

A. R. Docherty, H. Berenbaum, and J. G. Kerns, Alogia and formal thought disorder: differential patterns of verbal fluency task performance, J. Psychiatr. Res, vol.45, issue.10, pp.1352-1357, 2011.

G. Dölen, Autism: Oxytocin, serotonin, and social reward, Soc. Neurosci, vol.10, issue.5, pp.450-465, 2015.

E. Douven, S. Köhler, M. M. Rodriguez, J. Staals, F. R. Verhey et al., Imaging markers of post-stroke depression and apathy: A systematic review and meta-analysis, Neuropsychol. Rev, vol.27, issue.3, pp.202-219, 2017.

Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham et al., A meta-analysis of cytokines in major depression, Biol. Psychiatry, vol.67, issue.5, pp.446-457, 2010.

S. Durgam, W. Earley, A. Lipschitz, H. Guo, I. Laszlovszky et al., An 8-week randomized, double-blind, placebocontrolled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression, Am. J. Psychiatry, vol.173, issue.3, pp.271-281, 2016.

W. Earley, M. V. Burgess, L. Rekeda, R. Dickinson, B. Szatmári et al., Cariprazine treatment of bipolar depression: A randomized double-blind placebo-controlled phase 3 study, Am. J. Psychiatry, vol.176, issue.6, pp.439-448, 2019.

S. Engel, S. Laufer, C. Knaevelsrud, and S. Schumacher, The endogenous oxytocin system in depressive disorders: A systematic review and meta-analysis, Psychoneuroendocrinology, vol.101, pp.138-149, 2018.

. Eskelund, . Kasper, K. Karstoft, . Andersen, and B. Soren, Anhedonia and emotional numbing in treatment-seeking veterans: Behavioural and electrophysiological responses to reward, Eur. J. Psychotraumatol, vol.9, issue.1, p.1446616, 2018.

B. Etain, C. Henry, F. Bellivier, F. Mathieu, and M. Leboyer, Beyond genetics: Childhood affective trauma in bipolar disorder, Bipolar Disord, vol.10, issue.8, pp.867-876, 2008.

B. Etain, F. Mathieu, C. Henry, A. Raust, I. Roy et al., Preferential association between childhood emotional abuse and bipolar disorder, J. Trauma. Stress, vol.23, issue.3, pp.376-383, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00497585

H. A. Eyre, P. Siddarth, K. Van-dyk, N. S. Cyr, B. T. Baune et al., Neural correlates of apathy in late-life depression: A pilot [18 F] FDDNP positron emission tomography study, Psychogeriat. Off. J. Jpn. Psychogeriat. Soc, vol.17, issue.3, pp.186-193, 2017.

C. Fahim, E. Stip, A. Mancini-marïe, A. Gendron, B. Mensour et al., Differential hemodynamic brain activity in schizophrenia patients with blunted affect during quetiapine treatment, J. Clin. Psychopharmacol, vol.25, issue.4, pp.367-371, 2005.

F. Reddy, L. Green, M. F. Rizzo, S. Sugar, C. A. Blanchard et al., Behavioral approach and avoidance in schizophrenia: An evaluation of motivational profiles, Schizophr. Res, vol.159, issue.1, pp.164-170, 2014.

B. S. Fernandes, J. Steiner, H. Bernstein, S. Dodd, J. A. Pasco et al., C-Reactive protein is increased in schizophrenia but is not altered by antipsychotics: Meta-analysis and implications, Mol. Psychiatry, vol.21, issue.4, pp.554-564, 2016.

G. Fervaha, H. Takeuchi, G. Foussias, O. Agid, and G. Remington, Using poverty of speech as a case study to explore the overlap between negative symptoms and cognitive dysfunction, Schizophr. Res, vol.176, issue.2-3, pp.411-416, 2016.

W. Fleischhacker, . Galderisi, . Silvana, . Laszlovszky, . István et al., The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors, Eur. Psychiatry, vol.58, pp.1-9, 2019.

G. Fond, O. Godin, F. Schürhoff, F. Berna, B. Aouizerate et al., Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort, J. Affect. Disord, vol.245, pp.468-474, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02094172

G. Foussias and G. Remington, Negative symptoms in schizophrenia: Avolition and occam's razor, Schizophr. Bull, vol.36, issue.2, pp.359-369, 2010.

D. J. France, R. G. Shiavi, S. Silverman, M. Silverman, and D. M. Wilkes, Acoustical properties of speech as indicators of depression and suicidal risk, I.E.E.E. Trans. Biomed. Eng, vol.47, issue.7, pp.829-837, 2000.

T. Frodl, J. Scheuerecker, J. Albrecht, A. M. Kleemann, S. Müller-schunk et al., Neuronal correlates of emotional processing in patients with major depression, World J. Biol. Psychiatry Off. J. World Feder. Soc. Biol. Psychiatry, vol.10, issue.3, pp.202-208, 2009.

P. Fusar-poli, E. Papanastasiou, D. Stahl, M. Rocchetti, W. Carpenter et al., Treatments of negative symptoms in schizophrenia: Meta-analysis of 168 randomized placebo-controlled trials, Schizophr. Bull, vol.41, issue.4, pp.892-899, 2015.

. Fusar-poli, . Paolo, . Solmi, . Marco, . Brondino et al., Transdiagnostic psychiatry: A systematic review. World Psychiatry Off, J. World Psychiatric Assoc, vol.18, issue.2, pp.192-207, 2019.

W. Gaebel and W. Wölwer, Facial expression and emotional face recognition in schizophrenia and depression, Eur. Arch. Psychiatry Clin. Neurosci, vol.242, issue.1, pp.46-52, 1992.

D. Gallagher, A. Kiss, K. Lanctot, and N. Herrmann, Depression with inflammation: longitudinal analysis of a proposed depressive subtype in community dwelling older adults, Int. J. Geriatr. Psychiatry, vol.32, issue.12, pp.18-24, 2017.

D. E. Gard, A. M. Kring, M. G. Gard, W. P. Horan, and M. F. Green, Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure, Schizophr. Res, vol.93, issue.1-3, pp.253-260, 2007.

J. B. Garfield, D. I. Lubman, and M. Yücel, Anhedonia in substance use disorders: A systematic review of its nature, course and clinical correlates, Aust. N. Z. J. Psychiatry, vol.48, issue.1, pp.36-51, 2014.

J. Gehricke and D. Shapiro, Reduced facial expression and social context in major depression: Discrepancies between facial muscle activity and self-reported emotion, Psychiatry Res, vol.95, issue.2, pp.157-167, 2000.

B. R. Godlewska, R. Norbury, S. Selvaraj, P. J. Cowen, and C. J. Harmer, Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients, Psychol. Med, vol.42, issue.12, pp.2609-2617, 2012.

D. C. Goff, T. Bottiglieri, E. Arning, V. Shih, O. Freudenreich et al., Folate, homocysteine, and negative symptoms in schizophrenia, Am. J. Psychiatry, vol.161, issue.9, pp.1705-1708, 2004.

D. R. Goldsmith, E. Haroon, A. H. Miller, G. P. Strauss, P. F. Buckley et al., TNF-? and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia, Schizophr. Res, vol.199, pp.281-284, 2018.

G. M. Goodwin, J. Price, C. De-bodinat, and J. Laredo, Emotional blunting with antidepressant treatments: A survey among depressed patients, J. Affect. Disord, vol.221, pp.31-35, 2017.

V. B. Gradin, P. Kumar, G. Waiter, T. Ahearn, C. Stickle et al., Expected value and prediction error abnormalities in depression and schizophrenia, Brain J. Neurol, vol.134, pp.1751-1764, 2011.

I. Groeneweg-koolhoven, H. C. Comijs, P. Naarding, M. W. De-waal, and R. C. Van-der-mast, Apathy in older persons with depression: course and predictors: The NESDO study, J. Geriatr. Psychiatry Neurol, vol.29, issue.4, pp.178-186, 2016.

R. E. Gur, J. Loughead, C. G. Kohler, M. A. Elliott, K. Lesko et al., Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia, Arch. Gen. Psychiatry, vol.64, issue.12, pp.1356-1366, 2007.

E. S. Herbener and M. Harrow, Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis, Schizophr. Bull, vol.30, issue.4, pp.813-825, 2004.

R. Hershenberg, T. D. Satterthwaite, . Daldal, . Aylin, N. Katchmar et al., Diminished effort on a progressive ratio task in both unipolar and bipolar depression, J. Affect. Disord, vol.196, pp.97-100, 2016.

W. P. Horan, J. A. Pineda, J. K. Wynn, M. Iacoboni, and M. F. Green, Some markers of mirroring appear intact in schizophrenia: Evidence from Mu suppression, Cogn. Affect. Behav. Neurosci, vol.14, issue.3, pp.1049-1060, 2014.

O. D. Howes, . Mccutcheon, . Robert, M. J. Owen, and R. M. Murray, The role of genes, stress, and dopamine in the development of schizophrenia, Biol. Psychiatry, vol.81, issue.1, pp.9-20, 2017.

O. Howes, . Jauhar, . Sameer, . Brugger, . Stefan et al., 2 brain structural and neurochemical heterogeneity and homogeneity in psychotic disorders: Transdiagnostic PET and MRI imaging findings in schizophrenia and bipolar affective disorder, Schizophr. Bull, vol.9, issue.suppl_1, p.13, 2018.

T. Insel, B. Cuthbert, M. Garvey, R. Heinssen, D. S. Pine et al., Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders, Am. J. Psychiatry, vol.167, issue.7, pp.748-751, 2010.

A. Jablensky, Psychiatric classifications: Validity and utility. World Psychiatry Off, J. World Psychiatric Assoc, vol.15, issue.1, pp.26-31, 2016.

J. Jacus, Awareness, apathy, and depression in Alzheimer's disease and mild cognitive impairment, Brain Behav, vol.7, issue.4, p.661, 2017.

S. Jauhar, M. M. Nour, M. Veronese, M. Rogdaki, I. Bonoldi et al., A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia, JAMA Psychiat, vol.74, issue.12, pp.1206-1213, 2017.

L. M. Jenkins, M. T. Kassel, L. B. Gabriel, J. R. Gowins, E. A. Hymen et al., Amygdala and dorsomedial hyperactivity to emotional faces in youth with remitted major depression, Soc. Cogn. Affect. Neurosci, vol.11, issue.5, pp.736-745, 2016.

E. M. Joyce, S. L. Collinson, and P. Crichton, Verbal fluency in schizophrenia: Relationship with executive function, semantic memory and clinical alogia, Psychol. Med, vol.26, issue.1, pp.39-49, 1996.

S. Kaiser, . Lyne, . John, . Agartz, . Ingrid et al., Individual negative symptoms and domains -relevance for assessment, pathomechanisms and treatment, Schizophr. Res, vol.186, pp.39-45, 2017.

E. Karevold, E. Ystrom, R. J. Coplan, A. V. Sanson, and K. S. Mathiesen, A prospective longitudinal study of shyness from infancy to adolescence: Stability, age-related changes, and prediction of socio-emotional functioning, J. Abnorm. Child Psychol, vol.40, issue.7, pp.1167-1177, 2012.

J. Kasanin, The acute schizoaffective psychoses, Am. J. Psychiatry, vol.90, issue.1, pp.97-126, 1933.

Z. Kasanova, M. Oorschot, and I. Myin-germeys, Social anhedonia and asociality in psychosis revisited. An experience sampling study, Psychiatry Res, vol.270, pp.375-381, 2018.

S. Kéri, I. Kiss, and O. Kelemen, Sharing secrets: Oxytocin and trust in schizophrenia, Soc. Neurosci, vol.4, issue.4, pp.287-293, 2009.

B. Kirkpatrick, W. S. Fenton, W. T. Jr, and S. R. Marder, The NIMH-MATRICS consensus statement on negative symptoms, Schizophr. Bull, vol.32, issue.2, pp.214-219, 2006.

C. A. Köhler, T. H. Freitas, M. Maes, N. Q. De-andrade, C. S. Liu et al., Peripheral cytokine and chemokine alterations in depression: A metaanalysis of 82 studies, Acta Psychiatr. Scand, vol.135, issue.5, pp.373-387, 2017.

G. Konstantakopoulos, D. Ploumpidis, P. Oulis, P. Patrikelis, A. Soumani et al., Apathy, cognitive deficits and functional impairment in schizophrenia, Schizophr. Res, vol.133, issue.1-3, pp.193-198, 2011.

R. Kotov, R. F. Krueger, D. Watson, T. M. Achenbach, R. R. Althoff et al., The hierarchical taxonomy of psychopathology (HiTOP): A dimensional alternative to traditional nosologies, J. Abnorm. Psychol, vol.126, issue.4, pp.454-477, 2017.

M. Krause, Y. Zhu, M. Huhn, J. Schneider-thoma, I. Bighelli et al., Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: A systematic review and meta-analysis, Eur. Arch. Psychiatry Clin. Neurosci, vol.268, issue.7, pp.625-639, 2018.

A. M. Kring and E. K. Moran, Emotional response deficits in schizophrenia: Insights from affective science, Schizophr. Bull, vol.34, issue.5, pp.819-834, 2008.

V. Kumari, E. Peters, A. Guinn, D. Fannon, T. Russell et al., Mapping depression in schizophrenia: A functional magnetic resonance imaging study, Schizophr. Bull, vol.42, issue.3, pp.802-813, 2016.

A. Kupferberg, L. Bicks, and G. Hasler, Social functioning in major depressive disorder, Neurosci. Biobehav. Rev, vol.69, pp.313-332, 2016.

N. Lally, A. C. Nugent, D. A. Luckenbaugh, . Niciu, J. Mark et al., Neural correlates of change in major depressive disorder anhedonia following open-label ketamine, J. Psychopharmacol, vol.29, issue.5, pp.596-607, 2015.

C. Lambert, S. Da-silva, A. K. Ceniti, S. J. Rizvi, G. Foussias et al., Anhedonia in depression and schizophrenia: A transdiagnostic challenge, CNS Neurosci. Ther, vol.24, issue.7, pp.615-623, 2018.

J. S. Lee, J. W. Chun, S. Y. Yoon, H. Park, and J. Kim, Involvement of the mirror neuron system in blunted affect in schizophrenia, Schizophr. Res, vol.152, issue.1, pp.268-274, 2014.

E. J. Lenze, B. H. Mulsant, D. M. Blumberger, J. F. Karp, J. W. Newcomer et al., Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: A randomised, double-blind, placebo-controlled trial, The Lancet, vol.386, pp.2404-2412, 2015.

M. Lepage, K. Sergerie, A. Benoit, Y. Czechowska, E. Dickie et al., Emotional face processing and flat affect in schizophrenia: Functional and structural neural correlates, Psychol. Med, vol.41, issue.9, pp.1833-1844, 2011.

Y. Levkovitz, S. Mendlovich, S. Riwkes, Y. Braw, H. Levkovitch-verbin et al., A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia, J. Clin. Psychiatry, vol.71, issue.2, pp.138-149, 2010.

X. Li, Q. Li, J. Liu, L. Zhang, Y. Tang et al., Childhood trauma associates with clinical features of schizophrenia in a sample of Chinese inpatients, Psychiatry Res, vol.228, issue.3, pp.702-707, 2015.

E. J. Liemburg, J. J. Dlabac-de-lange, L. Bais, H. Knegtering, M. J. Van-osch et al., Neural correlates of planning performance in patients with schizophrenia-relationship with apathy, Schizophr. Res, vol.161, issue.2-3, pp.367-375, 2015.

C. Lindner, U. Dannlowski, J. Bauer, P. Ohrmann, R. Lencer et al., Affective flattening in patients with schizophrenia: Differential association with amygdala response to threat-related facial expression under automatic and controlled processing conditions, Psychiatry Investig, vol.13, issue.1, pp.102-111, 2016.

F. Liu, X. Guo, R. Wu, J. Ou, Y. Zheng et al., Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial, Schizophr. Res, vol.153, issue.1-3, pp.169-176, 2014.

R. V. Lutsenko, A. H. Sydorenko, and V. M. Bobyriov, Anhedonia at experimental models of chronic stress and its correction, Wiad. Lek, vol.70, issue.4, pp.745-750, 2017.

C. Mach and S. Dollfus, Scale for assessing negative symptoms in schizophrenia: A systematic review, L'Encephale, vol.42, issue.2, pp.165-171, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01547407

T. V. Maia and M. J. Frank, An integrative perspective on the role of dopamine in schizophrenia, Biol. Psychiatry, vol.81, issue.1, pp.52-66, 2017.

S. R. Marder and S. Galderisi, The current conceptualization of negative symptoms in schizophrenia. World Psychiatry Off, J. World Psychiatric Assoc, vol.16, issue.1, pp.14-24, 2017.

M. A. Marissen, N. Arnold, and I. H. Franken, Anhedonia in borderline personality disorder and its relation to symptoms of impulsivity, Psychopathology, vol.45, issue.3, pp.179-184, 2012.

S. L. Matheson, H. Vijayan, H. Dickson, A. M. Shepherd, V. J. Carr et al., Systematic meta-analysis of childhood social withdrawal in schizophrenia, and comparison with data from at-risk children aged 9-14 years, J. Psychiatr. Res, vol.47, issue.8, pp.1061-1068, 2013.

S. L. Matheson, A. M. Shepherd, R. M. Pinchbeck, K. R. Laurens, and V. J. Carr, Childhood adversity in schizophrenia: A systematic meta-analysis, Psychol. Med, vol.43, issue.2, pp.225-238, 2013.

T. Matthews, A. Danese, J. Wertz, C. L. Odgers, A. Ambler et al., Social isolation, loneliness and depression in young adulthood: A behavioural genetic analysis, Soc. Psychiatry Psychiatr. Epidemiol, vol.51, issue.3, pp.339-348, 2016.

C. Mccabe, P. J. Cowen, and C. J. Harmer, Neural representation of reward in recovered depressed patients, Psychopharmacology, vol.205, issue.4, pp.667-677, 2009.

J. M. Mccarthy, M. T. Treadway, M. E. Bennett, and J. J. Blanchard, Inefficient effort allocation and negative symptoms in individuals with schizophrenia, Schizophr. Res, vol.170, issue.2-3, pp.278-284, 2016.

A. G. Mckechanie, T. W. Moorhead, A. C. Stanfield, H. C. Whalley, E. C. Johnstone et al., Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: Preliminary findings from a 6-year follow-up study, Br. J. Psychiatry J. Mental Sci, vol.208, issue.6, pp.565-570, 2016.

D. L. Mcmakin, T. M. Olino, G. Porta, L. J. Dietz, G. Emslie et al., Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression, J. Am. Acad. Child Adolesc. Psychiatry, vol.51, issue.4, pp.404-411, 2012.

M. J. Millan, K. Fone, T. Steckler, and W. P. Horan, Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment, Eur. Neuropsychopharmacol, vol.24, issue.5, pp.645-692, 2014.

. Mitra, . Sumedha, . Natarajan, . Radhika, . Ziedonis et al., Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.78, pp.1-11, 2017.

C. S. Monk, R. G. Klein, . Telzer, H. Eva, E. A. Schroth et al., Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression, Am. J. Psychiatry, vol.165, issue.1, pp.90-98, 2008.

L. Mørch-johnsen, R. Nesvåg, A. Faerden, U. K. Haukvik, K. N. Jørgensen et al., Brain structure abnormalities in firstepisode psychosis patients with persistent apathy, Schizophr. Res, vol.164, issue.1-3, pp.59-64, 2015.

S. Moritz, A. Fritzsche, . Engel, . Maike, J. Meiseberg et al., A plea for a transdiagnostic conceptualization of negative symptoms and for consistent psychiatric vocabulary, Schizophr. Res. August, 2018.

R. W. Morris, S. Quail, K. R. Griffiths, M. J. Green, and B. W. Balleine, Corticostriatal control of goal-directed action is impaired in schizophrenia, Biol. Psychiatry, vol.77, issue.2, pp.187-195, 2015.

A. Mucci, D. Dima, A. Soricelli, U. Volpe, P. Bucci et al., Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback, Psychol. Med, vol.45, issue.8, pp.1765-1778, 2015.

. Na, . Kyoung-sae, . Won, . Eunsoo, J. Kang et al., Interaction effects of oxytocin receptor gene polymorphism and depression on hippocampal volume, Psychiatry Res. Neuroimag, vol.282, pp.18-23, 2018.

A. Nagels and T. Kircher, Chapter 71 -Symptoms and neurobiological models of language in schizophrenia, Neurobiology of Language, pp.887-897, 2016.

K. Nakamura, Y. Kawasaki, T. Takahashi, A. Furuichi, K. Noguchi et al., Reduced white matter fractional anisotropy and clinical symptoms in schizophrenia: A voxel-based diffusion tensor imaging study, Psychiatry Res, vol.202, issue.3, pp.233-238, 2012.

G. Németh, I. Laszlovszky, P. Czobor, E. Szalai, B. Szatmári et al., Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: A randomised, doubleblind, controlled trial, The Lancet, vol.389, pp.1103-1113, 2017.

A. A. Nierenberg, Residual symptoms in depression: Prevalence and impact, J. Clin. Psychiatry, vol.76, issue.11, p.1480, 2015.

A. Nikiforuk, M. Ho?uj, T. Kos, and P. Popik, The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia, Neuropharmacology, vol.105, pp.351-360, 2016.

T. Ohtani, S. Bouix, T. Hosokawa, Y. Saito, R. Eckbo et al., Abnormalities in white matter connections between orbitofrontal cortex and anterior cingulate cortex and their associations with negative symptoms in schizophrenia: A DTI study, Schizophr. Res, vol.157, issue.1-3, pp.190-197, 2014.

N. Ozaki, . Otsubo, . Tempei, . Kato, . Masaki et al., Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: A subgroup analysis and montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for depression item analyses of the aripiprazole depression multicenter efficacy study, Psychiatry Clin. Neurosci, vol.69, issue.1, pp.34-42, 2015.

A. Pampouchidou, O. Simantiraki, C. Vazakopoulou, C. Chatzaki, M. Pediaditis et al., Facial geometry and speech analysis for depression detection, Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society, pp.1433-1436, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01588556

I. H. Park, B. C. Lee, J. Kim, J. I. Kim, and M. Koo, Effort-based reinforcement processing and functional connectivity underlying amotivation in medicated patients with depression and schizophrenia, J. Neurosci. Off. J. Soc. Neurosci, vol.37, issue.16, pp.4370-4380, 2017.

M. S. Parris, M. F. Grunebaum, . Galfalvy, C. Hanga, A. Andronikashvili et al., Attempted suicide and oxytocin-related gene polymorphisms, J. Affect. Disord, vol.238, pp.62-68, 2018.

R. Patel, . Jayatilleke, . Nishamali, . Broadbent, C. Matthew et al., Negative symptoms in schizophrenia: A study in a large clinical sample of patients using a novel automated method, BMJ Open, vol.5, issue.9, p.7619, 2015.

P. Pechtel, S. J. Dutra, E. L. Goetz, and D. A. Pizzagalli, Blunted reward responsiveness in remitted depression, J. Psychiatr. Res, vol.47, issue.12, pp.1864-1869, 2013.

M. Peciña, M. Sikora, E. T. Avery, J. Heffernan, S. Peciña et al., Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response, Eur. Neuropsychopharmacol, vol.27, issue.10, pp.977-986, 2017.

M. A. Peluso, D. C. Glahn, K. Matsuo, E. Serap-monkul, P. Najt et al., Amygdala hyperactivation in untreated depressed individuals, Psychiatry Res, vol.173, issue.2, pp.158-161, 2009.

J. Pinto, . Vinícius, . Moulin, C. Thiago, . Amaral et al., On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review, Neurosci. Biobehav. Rev, vol.83, pp.97-108, 2017.

S. Porcelli, . Van-der-wee, . Nic, . Van-der-werff, . Steven et al., Social brain, social dysfunction and social withdrawal, Neurosci. Biobehav. Rev. September, 2018.

R. M. Post, Comparative pharmacology of bipolar disorder and schizophrenia, Schizophr. Res, vol.39, issue.2, pp.153-158, 1999.

E. Quattrocki and K. Friston, Autism, oxytocin and interoception, Neurosci. Biobehav. Rev, vol.47, pp.410-430, 2014.

D. Quattrone, D. Forti, . Marta, C. Gayer-anderson, . Ferraro et al., Transdiagnostic dimensions of psychopathology at first episode psychosis: Findings from the multinational EU-GEI Study, Psychol. Med. October, pp.1-14, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01915324

J. Radua, A. Schmidt, S. Borgwardt, A. Heinz, F. Schlagenhauf et al., Ventral striatal activation during reward processing in psychosis: A neurofunctional meta-analysis, JAMA Psychiat, vol.72, issue.12, pp.1243-1251, 2015.

. Raffard, . Stéphane, . Esposito, . Fabienne, . Boulenger et al., Impaired ability to imagine future pleasant events is associated with apathy in schizophrenia, Psychiatry Res, vol.209, issue.3, pp.393-400, 2013.

A. B. Ragin, M. Pogue-geile, and T. F. Oltmanns, Poverty of speech in schizophrenia and depression during in-patient and post-hospital periods, Br. J. Psychiatry J. Mental Sci, vol.154, pp.52-57, 1989.

J. Richter, . Hölz, . Lea, . Hesse, . Klaus et al., Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression, Eur. Psychiatry, vol.55, pp.23-28, 2018.

M. S. Ritsner, M. Arbitman, and A. Lisker, Anhedonia is an important factor of healthrelated quality-of-life deficit in schizophrenia and schizoaffective disorder, J. Nerv. Ment. Dis, vol.199, issue.11, pp.845-853, 2011.

G. Rizzolatti and L. Craighero, The mirror-neuron system, Annu. Rev. Neurosci, 2004.

D. Rodrigues-amorim, . Rivera-baltanás, . Tania, . Spuch, . Carlos et al., Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship, Schizophr. Res, vol.197, pp.19-33, 2018.

J. L. Roffman, L. J. Petruzzi, A. S. Tanner, H. E. Brown, H. Eryilmaz et al., Biochemical, physiological and clinical effects of L-methylfolate in schizophrenia: A randomized controlled trial, Mol. Psychiatry, vol.23, issue.2, pp.316-322, 2018.

J. D. Rosenblat and R. S. Mcintyre, Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials, J. Affect. Disord, vol.227, pp.219-225, 2018.

S. Rosenman, A. Korten, J. Medway, and M. Evans, Dimensional vs. categorical diagnosis in psychosis, Acta Psychiatr. Scand, vol.107, issue.5, pp.378-384, 2003.

R. M. Roth, L. A. Flashman, A. J. Saykin, T. W. Mcallister, and R. Vidaver, Apathy in schizophrenia: Reduced frontal lobe volume and neuropsychological deficits, Am. J. Psychiatry, vol.161, issue.1, pp.157-159, 2004.

K. H. Rubin, R. J. Coplan, and J. C. Bowker, Social withdrawal in childhood, Annu. Rev. Psychol, vol.60, pp.141-171, 2009.

C. J. Ruggero, G. A. Carlson, . Kotov, . Roman, and E. J. Bromet, Tenyear diagnostic consistency of bipolar disorder in a first-admission sample, Bipolar Disord, vol.12, issue.1, pp.21-31, 2010.

M. ?agud, I. Filip?i?, N. Jak?i?, L. ?imuni?, D. Jezernik et al., Anhedonia in schizophrenia: Mini-review, Psychiatr. Danub, vol.31, pp.143-147, 2019.

C. Sahin, . Doostdar, . Nazanin, and J. C. Neill, Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model, Behav. Brain Res, vol.312, pp.93-101, 2016.

Y. Saito, M. Kubicki, I. Koerte, T. Otsuka, Y. Rathi et al., Impaired white matter connectivity between regions containing mirror neurons, and relationship to negative symptoms and social cognition, in patients with first-episode schizophrenia, Brain Imaging Behav, vol.12, issue.1, pp.229-237, 2018.

K. Sakuma, S. Matsunaga, I. Nomura, M. Okuya, T. Kishi et al., Folic acid/ methylfolate for the treatment of psychopathology in schizophrenia: A systematic review and meta-analysis, Psychopharmacology, vol.235, issue.8, pp.2303-2314, 2018.

C. Schefft, L. L. Kilarski, T. Bschor, and S. Köhler, Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis, Eur. Neuropsychopharmacol, vol.27, issue.11, pp.1090-1109, 2017.

A. Schmidt, M. Cappucciati, J. Radua, G. Rutigliano, M. Rocchetti et al., Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and meta-analytical sequential testing simulation, Schizophr. Bull, vol.43, issue.2, pp.375-388, 2017.

M. Serper, E. Payne, C. Dill, C. Portillo, and J. Taliercio, Allocating effort and anticipating pleasure in schizophrenia: Relationship with real world functioning, Eur. Psychiatry, vol.46, pp.57-64, 2017.

C. E. Sexton, C. E. Mackay, and K. P. Ebmeier, A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression, Am. J. Geriat. Psychiatry Off. J. Am. Assoc. Geriat. Psychiatry, vol.21, issue.2, pp.184-195, 2013.

J. J. Shaffer, M. J. Peterson, M. A. Mcmahon, J. Bizzell, V. Calhoun et al., Neural correlates of schizophrenia negative symptoms: Distinct subtypes impact dissociable brain circuits, Mol. Neuropsych, vol.1, issue.4, pp.191-200, 2015.

A. Sharma, D. H. Wolf, R. Ciric, J. W. Kable, T. M. Moore et al., Common dimensional reward deficits across mood and psychotic disorders: A connectome-wide association study, Am. J. Psychiatry, vol.174, issue.7, pp.657-666, 2017.

L. Sherdell, C. E. Waugh, and I. H. Gotlib, Anticipatory pleasure predicts motivation for reward in major depression, J. Abnorm. Psychol, vol.121, issue.1, pp.51-60, 2012.

A. Sicras-mainar, J. Maurino, E. Ruiz-beato, and R. Navarro-artieda, Impact of negative symptoms on healthcare resource utilization and associated costs in adult outpatients with schizophrenia: A population-based study, BMC Psychiatry, vol.14, p.225, 2014.

G. J. Siegle, . Thompson, . Wesley, C. S. Carter, . Steinhauer et al., Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: Related and independent features, Biol. Psychiatry, vol.61, issue.2, pp.198-209, 2007.

J. J. Simon, A. Biller, S. Walther, D. Roesch-ely, C. Stippich et al., Neural correlates of reward processing in schizophrenia-relationship to apathy and depression, Schizophr. Res, vol.118, issue.1-3, pp.154-161, 2010.

S. P. Singh, V. Singh, N. Kar, and K. Chan, Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: Meta-analysis, Br. J. Psychiatry J. Mental Sci, vol.197, issue.3, pp.174-179, 2010.

C. L. Slaney, C. A. Hales, and E. S. Robinson, Rat models of reward deficits in psychiatric disorders, Curr. Opin. Behav. Sci, vol.22, pp.136-142, 2018.

N. C. Stefanis, M. Hanssen, N. K. Smirnis, D. A. Avramopoulos, I. K. Evdokimidis et al., Evidence that three dimensions of psychosis have a distribution in the general population, Psychol. Med, vol.32, issue.2, pp.347-358, 2002.

S. Steudte-schmiedgen, S. Wichmann, T. Stalder, K. Hilbert, M. Muehlhan et al., Hair cortisol concentrations and cortisol stress reactivity in generalized anxiety disorder, major depression and their comorbidity, J. Psychiatr. Res, vol.84, pp.184-190, 2017.

E. Stip, C. Fahim, P. Liddle, A. Mancini-marïe, B. Mensour et al., Neural correlates of sad feelings in schizophrenia with and without blunted affect, Can. J. Psychiatry. Rev. Can. Psychiatrie, vol.50, issue.14, pp.909-917, 2005.

G. P. Strauss and A. S. Cohen, A transdiagnostic review of negative symptom phenomenology and etiology, Schizophr. Bull, vol.43, issue.4, pp.712-719, 2017.

G. P. Strauss and J. M. Gold, A new perspective on anhedonia in schizophrenia, Am. J. Psychiatry, vol.169, issue.4, pp.364-373, 2012.

G. P. Strauss, W. R. Keller, J. I. Koenig, J. M. Gold, K. L. Ossenfort et al., Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia, Schizophr. Res, vol.162, issue.1-3, pp.57-61, 2015.

G. P. Strauss, F. Z. Esfahlani, S. Galderisi, A. Mucci, A. Rossi et al., Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia, Schizophr. Bull, vol.45, issue.5, pp.1033-1041, 2018.

S. Surguladze, M. J. Brammer, P. Keedwell, V. Giampietro, A. W. Young et al., A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder, Biol. Psychiatry, vol.57, issue.3, pp.201-209, 2005.

R. Tandon, W. Gaebel, D. M. Barch, . Bustillo, . Juan et al., Definition and description of schizophrenia in the DSM-5, Schizophr. Res, vol.150, issue.1, pp.3-10, 2013.

S. I. Tarbox and M. F. Pogue-geile, Development of social functioning in preschizophrenia children and adolescents: A systematic review, Psychol. Bull, vol.134, issue.4, pp.561-583, 2008.

C. Tas, . Brown, C. Elliot, . Eskikurt, . Gokcer et al., Cortisol response to stress in schizophrenia: Associations with oxytocin, social support and social functioning, Psychiatry Res, 2018.

F. Trémeau, A review of emotion deficits in schizophrenia, Dialogues Clin. Neurosci, vol.8, issue.1, pp.59-70, 2006.

F. Trémeau, . Malaspina, . Dolores, F. Duval, H. Corrêa et al., Facial expressiveness in patients with schizophrenia compared to depressed patients and nonpatient comparison subjects, Am. J. Psychiatry, vol.162, issue.1, pp.92-101, 2005.

R. Uher, R. H. Perlis, N. Henigsberg, A. Zobel, M. Rietschel et al., Depression symptom dimensions as predictors of antidepressant treatment outcome: Replicable evidence for interest-activity symptoms, Psychol. Med, vol.42, issue.5, pp.967-980, 2012.

M. Van-nierop, W. Viechtbauer, N. Gunther, V. C. Zelst, D. R. Graaf et al., Childhood trauma is associated with a specific admixture of affective, anxiety, and psychosis symptoms cutting across traditional diagnostic boundaries, Psychol. Med, vol.45, issue.6, pp.1277-1288, 2015.

J. Van-os and U. Reininghaus, Psychosis as a transdiagnostic and extended phenotype in the general population, World Psychiatry Off. J. World Psychiatric Assoc, vol.15, issue.2, pp.118-124, 2016.

T. A. Victor, M. L. Furey, S. J. Fromm, A. Ohman, and W. C. Drevets, Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder, Arch. Gen. Psychiatry, vol.67, issue.11, pp.1128-1138, 2010.

F. Vinckier, D. Gourion, and S. Mouchabac, Anhedonia predicts poor psychosocial functioning: Results from a large cohort of patients treated for major depressive disorder by general practitioners, Eur. Psychiatry, vol.44, pp.1-8, 2017.

J. A. Waltz, M. J. Frank, B. M. Robinson, and J. M. Gold, Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction, Biol. Psychiatry, vol.62, issue.7, pp.756-764, 2007.

K. J. Wardenaar, S. A. Vreeburg, T. Van-veen, E. J. Giltay, G. Veen et al., Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis, Biol. Psychiatry, vol.69, issue.4, pp.366-373, 2011.

A. Weinberg and S. A. Shankman, Blunted reward processing in remitted melancholic depression, Clin. Psychol. Sci, vol.5, issue.1, pp.14-25, 2017.

M. Wen, L. L. Chan, L. C. Tan, and E. K. Tan, Depression, anxiety, and apathy in parkinson's disease: Insights from neuroimaging studies, Eur. J. Neurol. Off. J. Eur. Feder. Neurol. Soc, vol.23, issue.6, pp.1001-1019, 2016.

N. Werbeloff, . Dohrenwend, P. Bruce, . Yoffe, . Rinat et al., The association between negative symptoms, psychotic experiences and later schizophrenia: A population-based longitudinal study, PLoS One, vol.10, issue.3, p.119852, 2015.

A. E. Whitton, M. T. Treadway, and D. A. Pizzagalli, Reward processing dysfunction in major depression, bipolar disorder and schizophrenia, Curr. Opin. Psychiatry, vol.28, issue.1, pp.7-12, 2015.

C. Winograd-gurvich, P. B. Fitzgerald, N. Georgiou-karistianis, J. L. Bradshaw, and O. B. White, Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease, Brain Res. Bull, vol.70, issue.4-6, pp.312-321, 2006.

K. Wolf, R. Mass, F. Kiefer, K. Wiedemann, and D. Naber, Characterization of the facial expression of emotions in schizophrenia patients: Preliminary findings with a new electromyography method, Can. J. Psychiatry. Rev. Can. Psychiatrie, vol.51, issue.6, pp.335-341, 2006.

D. H. Wolf, T. D. Satterthwaite, J. J. Kantrowitz, N. Katchmar, L. Vandekar et al., Amotivation in schizophrenia: Integrated assessment with behavioral, clinical, and imaging measures, Schizophr. Bull, vol.40, issue.6, pp.1328-1337, 2014.

K. Yu, . Cheung, . Charlton, . Leung, . Meikei et al., Are bipolar disorder and schizophrenia neuroanatomically distinct? An anatomical likelihood meta-analysis, Front. Hum. Neurosci, vol.4, p.189, 2010.

G. S. Yuen, F. M. Gunning, E. Woods, S. A. Klimstra, M. J. Hoptman et al., Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response, J. Affect. Disord, vol.166, pp.179-186, 2014.

G. S. Yuen, S. Bhutani, B. J. Lucas, F. M. Gunning, B. Abdelmalak et al., Apathy in late-life depression: Common, persistent, and disabling, Am. J. Geriat. Psychiatry Off. J. Am. Assoc. Geriat. Psychiatry, vol.23, issue.5, pp.488-494, 2015.

P. Zachar and K. S. Kendler, PsycNET, 2010.

B. Zhang, P. Lin, H. Shi, D. Öngür, R. P. Auerbach et al., Mapping anhedonia-specific dysfunction in a transdiagnostic approach: An ALE metaanalysis, Brain Imaging Behav, vol.10, issue.3, pp.920-939, 2016.